Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth T Birzin

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Assay and Drug Development Technologies|April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well formatNorbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 2008
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterusAngela Scafonas, Alfred A Reszka, Donald B Kimmel, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2005
Androstenediol analogs as ER-beta-selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Journal of Medicinal Chemistry|April 16, 2004
Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulatorsSeongkon Kim, Jane Y Wu, Elizabeth T Birzin, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2007
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalphaKevin D Dykstra, Liangqin Guo, Elizabeth T Birzin, et al.
Molecular Endocrinology (Baltimore, Md.)|October 15, 2005
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylationLorraine Lipfert, John E Fisher, Nan Wei, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkersTimothy A Blizzard, Frank Dininno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Assay and Drug Development Technologies|April 20, 2004
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well formatNorbert T Peekhaus, Marc Ferrer, Tina Chang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 2008
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterusAngela Scafonas, Alfred A Reszka, Donald B Kimmel, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2005
Androstenediol analogs as ER-beta-selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Journal of Medicinal Chemistry|April 16, 2004
Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulatorsSeongkon Kim, Jane Y Wu, Elizabeth T Birzin, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2007
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalphaKevin D Dykstra, Liangqin Guo, Elizabeth T Birzin, et al.
Molecular Endocrinology (Baltimore, Md.)|October 15, 2005
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylationLorraine Lipfert, John E Fisher, Nan Wei, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkersTimothy A Blizzard, Frank Dininno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Pageof 3